Javascript must be enabled to continue!
Alkynyl Prins and Alkynyl Aza-Prins Annulations: Scope and Synthetic Applications
View through CrossRef
This review focuses on alkynyl Prins and alkynyl aza-Prins cyclization processes, which involve intramolecular coupling of an alkyne with either an oxocarbenium or iminium electrophile. The oxocarbenium or iminium species can be generated through condensation- or elimination-type processes, to achieve an overall bimolecular annulation that enables the synthesis of both oxygen- and nitrogen-containing saturated heterocycles with different ring sizes and substitution patterns. Also discussed are cascade processes in which alkynyl Prins heterocyclic adducts react to trigger subsequent pericyclic reactions, including [4+2] cycloadditions and Nazarov electrocyclizations, to rapidly construct complex small molecules. Finally, examples of the use of alkynyl Prins and alkynyl aza-Prins reactions in the synthesis of natural products are described. The review covers the literature through the end of 2019.1 Introduction1.1 Alkyne-Carbonyl Coupling Pathways1.2 Coupling/Cyclization Cascades Using the Alkynyl Prins Reaction2 Alkynyl Prins Annulation (Oxocarbenium Electrophiles)2.1 Early Work2.2 Halide as Terminal Nucleophile2.3 Oxygen as Terminal Nucleophile2.4 Arene as Terminal Nucleophile (Intermolecular)2.5 Arene Terminal Nucleophile (Intramolecular)2.6 Cyclizations Terminated by Elimination3 Synthetic Utility of Alkynyl Prins Annulation3.1 Alkynyl Prins-Mediated Synthesis of Dienes for a [4+2] Cyclo- addition-Oxidation Sequence3.2 Alkynyl Prins Cyclization Adducts as Nazarov Cyclization Precursors3.3 Alkynyl Prins Cyclization in Natural Product Synthesis4 Alkynyl Aza-Prins Annulation4.1 Iminium Electrophiles4.2 Activated Iminium Electrophiles5 Alkynyl Aza-Prins Cyclizations in Natural Product Synthesis6 Summary and Outlook
Title: Alkynyl Prins and Alkynyl Aza-Prins Annulations: Scope and Synthetic Applications
Description:
This review focuses on alkynyl Prins and alkynyl aza-Prins cyclization processes, which involve intramolecular coupling of an alkyne with either an oxocarbenium or iminium electrophile.
The oxocarbenium or iminium species can be generated through condensation- or elimination-type processes, to achieve an overall bimolecular annulation that enables the synthesis of both oxygen- and nitrogen-containing saturated heterocycles with different ring sizes and substitution patterns.
Also discussed are cascade processes in which alkynyl Prins heterocyclic adducts react to trigger subsequent pericyclic reactions, including [4+2] cycloadditions and Nazarov electrocyclizations, to rapidly construct complex small molecules.
Finally, examples of the use of alkynyl Prins and alkynyl aza-Prins reactions in the synthesis of natural products are described.
The review covers the literature through the end of 2019.
1 Introduction1.
1 Alkyne-Carbonyl Coupling Pathways1.
2 Coupling/Cyclization Cascades Using the Alkynyl Prins Reaction2 Alkynyl Prins Annulation (Oxocarbenium Electrophiles)2.
1 Early Work2.
2 Halide as Terminal Nucleophile2.
3 Oxygen as Terminal Nucleophile2.
4 Arene as Terminal Nucleophile (Intermolecular)2.
5 Arene Terminal Nucleophile (Intramolecular)2.
6 Cyclizations Terminated by Elimination3 Synthetic Utility of Alkynyl Prins Annulation3.
1 Alkynyl Prins-Mediated Synthesis of Dienes for a [4+2] Cyclo- addition-Oxidation Sequence3.
2 Alkynyl Prins Cyclization Adducts as Nazarov Cyclization Precursors3.
3 Alkynyl Prins Cyclization in Natural Product Synthesis4 Alkynyl Aza-Prins Annulation4.
1 Iminium Electrophiles4.
2 Activated Iminium Electrophiles5 Alkynyl Aza-Prins Cyclizations in Natural Product Synthesis6 Summary and Outlook.
Related Results
Evaluation Of Acadesine, a Drug Stimulating Cell Autophagy, In Azacitidine(AZA)-Resistant Myelodysplastic Syndromes (MDS)
Evaluation Of Acadesine, a Drug Stimulating Cell Autophagy, In Azacitidine(AZA)-Resistant Myelodysplastic Syndromes (MDS)
Abstract
Background
AZA is currently the first line treatment for intermediate-2 and high-risk IPSS myelodysplastic syndromes (M...
An unusual adverse event of azathioprine: Cutaneous small vessel vasculitis
An unusual adverse event of azathioprine: Cutaneous small vessel vasculitis
In this article, we present a Japanese female case of cutaneous small vessel vasculitis (CSVV) after administration of oral azathioprine (AZA).
A 56-year-old Japanese woman with l...
Modulation of CD81 By Epigenetic Drug Combination Sensitizes Acute Lymphoblastic Leukemia Via Decreased BTK Signaling
Modulation of CD81 By Epigenetic Drug Combination Sensitizes Acute Lymphoblastic Leukemia Via Decreased BTK Signaling
Background
We previously discovered that the epigenetic drug combination - azacitidine (aza, DNMTi) and panobinostat (pano, HDACi) can sensitize ALL cells to chemoth...
pVAX14 DNA, An Immunoadjuvant, Extends Life-Span As Add-On Treatment To Azacitidine (AZA) In A Mouse Model Of High Risk Myelodysplastic Syndrome (HR-MDS)
pVAX14 DNA, An Immunoadjuvant, Extends Life-Span As Add-On Treatment To Azacitidine (AZA) In A Mouse Model Of High Risk Myelodysplastic Syndrome (HR-MDS)
Abstract
Background
We have established animal models of MDS and acute myelogenous leukemia (AML) using NRASD12 and overexpressi...
Heterotricyclodecane. XXIV. 2‐Aza‐7‐oxa‐twistane (bzw. 2‐Oxa‐7‐aza‐twistane) und 2‐Aza‐7‐oxa‐isotwistane
Heterotricyclodecane. XXIV. 2‐Aza‐7‐oxa‐twistane (bzw. 2‐Oxa‐7‐aza‐twistane) und 2‐Aza‐7‐oxa‐isotwistane
2‐Aza‐7‐oxa‐twistanes (or 2‐oxa‐7‐aza‐twistanes, respectively)Die nicht mit den IUPAC‐Regeln übereinstimmende Numerierung (b): 2‐Aza‐7‐oxa‐twistane, Substituent an C(10) (vgl. Korr...
Organocatalytic aza‐Michael/retro‐aza‐Michael reaction: Pronounced chirality amplification in aza‐Michael reaction and racemization via retro‐aza‐Michael reaction
Organocatalytic aza‐Michael/retro‐aza‐Michael reaction: Pronounced chirality amplification in aza‐Michael reaction and racemization via retro‐aza‐Michael reaction
AbstractA detailed experimental investigation of an aza‐Michael reaction of aniline and chalcone is presented. A series of Cinchona alkaloid‐derived organocatalysts with different ...
Abstract 2842: 5-aza-2’-Deoxycytidine induces cellular senescence in non-small cell lung cancer
Abstract 2842: 5-aza-2’-Deoxycytidine induces cellular senescence in non-small cell lung cancer
Abstract
Background: Lung cancer is one of the refractory malignancies and the leading cause of cancer-related death worldwide. Although prognosis of lung cancer was...
Response To Azacitidine Is Independent Of TP53 Mutations In Higher-Risk Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (sAML)
Response To Azacitidine Is Independent Of TP53 Mutations In Higher-Risk Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (sAML)
Abstract
Introduction
Higher-risk myelodysplastic syndromes (MDS) progress to secondary acute myeloid leukemia (sAML) within mon...

